Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
During treatment with sotorasib, consuming large amounts of greasy food is generally not recommended. However, small or occasional intake is usually acceptable, depending on indivi···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：176
Selpercatinib is a targeted therapy for specific gene mutations (such as RET fusion-positive), primarily used to treat malignant tumors such as thyroid cancer and non-small cell lu···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：53
Selpercatinib is a targeted therapy designed for specific gene mutations (such as RET fusions or mutations), primarily used to treat malignancies like non-small cell lung cancer an···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：44
The price of stiripentol is influenced by factors such as specification, dosage, and purchasing channel, typically ranging from hundreds to thousands of yuan. The exact cost should···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：67
Mobocertinib is an oral targeted therapy primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations. Its ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：50
Mobocertinib is a targeted therapy drug for non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Its common side effects include diarrhea, rash, stomatitis, na···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：52
The current price of Mobocertinib after medical insurance reimbursement in China is influenced by specific circumstances. If you choose the generic version produced in India, the p···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：55
The current price of Mobocertinib is influenced by purchasing channels, regional policies, and medical insurance coverage. This medication must be used strictly under the guidance ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：71
The usual recommended dose of sotorasib is 960 mg (8 tablets x 120 mg) once daily, taken on an empty stomach at least 1 hour before or 2 hours after eating. Specific usage must be ···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：61
Sotorasib is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer (NSCLC). Its price varies significantly depending on region, specification, purchasing channel, and···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：58
Lumykras (generic name: Sotorasib) is a prescription targeted therapy drug for non-small cell lung cancer (NSCLC) that targets a specific gene mutation (KRAS G12C). Its price is in···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：65
The price of Sotorasib varies significantly depending on the region, purchasing channel, and specification. For specific prices, please refer to the actual selling prices at hospit···【more】
Article source：Captain MedicineRelease date：2026-02-25Recommended：65
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2272025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4532024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2322025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2452025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2252025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2532025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2352025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2162025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
